Survival in early-stage non-small cell lung cancer.

[1]  S. Rodenhuis,et al.  K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. , 1990, The New England journal of medicine.

[2]  M. Noguchi,et al.  Clinicopathologic characteristics of adenosquamous carcinoma of the lung , 1991, Cancer.

[3]  D. Moores.  Staging of lung cancer. , 1987, The Annals of thoracic surgery.

[4]  Holmes Ec.  Treatment of stage II lung cancer (T1N1 and T2N1). , 1987 .

[5]  V. Gorgoulis,et al.  Expression of EGF, TGF-alpha and EGFR in squamous cell lung carcinomas. , 1992, Anticancer research.

[6]  A. Harris,et al.  bcl-2 protein in non-small-cell lung carcinoma. , 1993, The New England journal of medicine.

[7]  P. Thomas,et al.  Cancer recurrence after resection: T1 N0 non-small cell lung cancer. Lung Cancer Study Group. , 1990, The Annals of thoracic surgery.

[8]  L. Zhang.  [Results of surgical treatment of stage I non-small cell lung cancer]. , 1993, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[9]  M. Gail,et al.  Prognostic factors in patients with resected stage I non‐small cell lung cancer. A report from the Lung Cancer Study Group , 1984, Cancer.

[10]  N. Martini,et al.  Complications of surgery in the treatment of carcinoma of the lung. , 1982, Chest.

[11]  S. Rodenhuis,et al.  Clinical significance of ras oncogene activation in human lung cancer. , 1992, Cancer research.

[12]  C. Mountain,et al.  Value of the New TNM Staging System for Lung Cancer , 1989 .

[13]  D. Weiner,et al.  p185neu expression in human lung adenocarcinomas predicts shortened survival. , 1990, Cancer research.

[14]  M. Teramachi,et al.  [Results of surgery in non-small cell lung cancer]. , 1990, Bulletin of the Chest Disease Research Institute, Kyoto University.

[15]  L. Rubinstein,et al.  Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  S. Steinberg,et al.  ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent. , 1991, Cancer research.

[17]  G. van Kaick,et al.  New aspects in the staging of lung cancer. Prospective validation of the international union against cancer TNM classification , 1992, Cancer.

[18]  J. Deslauriers,et al.  Carcinoma of the lung. Evaluation of satellite nodules as a factor influencing prognosis after resection. , 1989, The Journal of thoracic and cardiovascular surgery.

[19]  A. Sahin,et al.  Expression of blood-group antigen A--a favorable prognostic factor in non-small-cell lung cancer. , 1991, The New England journal of medicine.

[20]  R. Smith,et al.  Tumour size as a prognostic factor after resection of lung carcinoma. , 1977, Thorax.

[21]  J. Régnard,et al.  Primary lung cancer in young patients: a study of 82 surgically treated patients. , 1992, The Annals of thoracic surgery.

[22]  C. Kittle.  Current Controversies in Thoracic Surgery , 1986 .

[23]  M. Oda,et al.  Proposals regarding some deficiencies in the new international staging system for non-small cell lung cancer. , 1991, Japanese journal of clinical oncology.

[24]  A. Rubin,et al.  Lung cancer in young adults. , 1992, Chest.

[25]  J. Pater,et al.  Nonanatomic prognostic factors in carcinoma of the lung. A multivariate analysis , 1982, Cancer.

[26]  C. Angeletti,et al.  Most peripheral, node-negative, non-small-cell lung cancers have low proliferative rates and no intratumoral and peritumoral blood and lymphatic vessel invasion. Rationale for treatment with wedge resection alone. , 1992, The Journal of thoracic and cardiovascular surgery.

[27]  C. Angeletti,et al.  Blood vessel invasion by tumor cells predicts recurrence in completely resected T1 N0 M0 non-small-cell lung cancer. , 1993, The Journal of thoracic and cardiovascular surgery.

[28]  M. Oda,et al.  Early hilar lung cancer: Its clinical aspect , 1991, Journal of surgical oncology.

[29]  D. Quinlan,et al.  Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. , 1992, Cancer research.

[30]  H. Dosaka-akita,et al.  Prognostic significance of the expression of ras oncogene product in non‐small cell lung cancer , 1992, Cancer.

[31]  T. Treasure,et al.  Prognosis of peripheral lung tumours related to size of the primary. , 1981, Thorax.

[32]  C. Mountain.  The new International Staging System for Lung Cancer. , 1986, The Surgical clinics of North America.

[33]  T. Mitsudomi,et al.  Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small-cell lung cancer. , 1993, Journal of the National Cancer Institute.

[34]  K. Sugimachi,et al.  Strategy for lymphadenectomy in lung cancer three centimeters or less in diameter. , 1990, The Annals of thoracic surgery.

[35]  R. Tsuchiya,et al.  Prognosis and survival in resected lung carcinoma based on the new international staging system. , 1988, The Journal of thoracic and cardiovascular surgery.

[36]  R. Read,et al.  Survival after conservative resection for T1 N0 M0 non-small cell lung cancer. , 1990, The Annals of thoracic surgery.

[37]  H. Libshitz,et al.  Roentgenographic evaluation of mediastinal nodes for preoperative assessment in lung cancer. , 1985, Chest.

[38]  E. Ruffini,et al.  Resection and radical lymphadenectomy for lung cancer: prognostic significance of lymphatic metastases. , 1990, International surgery.

[39]  G. Motta.  Lung cancer : frontiers in science and treatment , 1994 .

[40]  R. Ginsberg,et al.  Prognostic factors in non-small cell lung cancer. , 1991, Lung cancer.

[41]  T Takahashi,et al.  Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer. , 1993, Cancer research.

[42]  J. Yee,et al.  Relationship of cell type and lymph node metastasis to survival after resection of bronchial carcinoma. , 1975, The Annals of thoracic surgery.

[43]  L. A. Brewer.  Patterns of survival in lung cancer. , 1977, Chest.

[44]  D. Page,et al.  Lung cancer classification: The relationship of disease extent and cell type to survival in a clinical trials population , 1987, Journal of surgical oncology.

[45]  G. Silvestri,et al.  Prognostic significance of tumor proliferative fraction and DNA content in stage I non-small cell lung cancer. , 1992, The American review of respiratory disease.

[46]  M. Oda,et al.  [Results of surgical treatment of stage I lung cancer]. , 1993, Nihon Geka Gakkai zasshi.

[47]  G. Freise,et al.  Bronchial carcinoma and long-term survival. Retrospective study of 433 patients who underwent resection. , 1978, Thorax.

[48]  Y. Ichinose,et al.  Surgical results and prognostic factors of pathologic N1 disease in non-small-cell carcinoma of the lung. Significance of N1 level: lobar or hilar nodes. , 1994, The Journal of thoracic and cardiovascular surgery.

[49]  R. Walls,et al.  Diameter, cell type, and survival in stage I primary non-small-cell lung cancer. , 1988, Archives of surgery.

[50]  V. Rusch,et al.  Survival after resection of stage II non-small cell lung cancer. , 1992, The Annals of thoracic surgery.

[51]  S. Medendorp,et al.  Expression of blood group antigen A by stage I non-small cell lung carcinomas. , 1995, The Annals of thoracic surgery.

[52]  J. Coquillaud.  INTERNATIONAL TRENDS IN GENERAL THORACIC SURGERY , 1987 .

[53]  W F Taylor,et al.  Survival of patients surgically treated for stage I lung cancer. , 1981, The Journal of thoracic and cardiovascular surgery.

[54]  Y. Ichinose,et al.  Is T factor of the TNM staging system a predominant prognostic factor in pathologic stage I non-small-cell lung cancer ? A multivariate prognostic factor analysis of 151 patients. , 1993, The Journal of thoracic and cardiovascular surgery.

[55]  J. Dussek,et al.  Survival and prognosis following resection of primary non small cell bronchogenic carcinoma. , 1991, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.